Cartesian Therapeutics (NASDAQ:RNAC) Receives “Buy” Rating from Needham & Company LLC

Chronological Source Flow
Back

AI Fusion Summary

Cartesian Therapeutics (NASDAQ:RNAC) and Immuneering (NASDAQ:IMRX) both received a 'Buy' rating from Needham & Company LLC, indicating the firm's positive outlook on each company's prospects and potential investment value for investors.
#CARTESIAN_THERAPEUTICS #IMMUNEERING #BUY_RATING #NEEDHAM_COMPANY #NASDAQ #US_STOCKS #INVESTMENT_OPPORTUNITY
10/03 08:50 defenseworld.net
2 Πηγές

Cartesian Therapeutics (NASDAQ:RNAC) Receives “Buy” Rating from Needham & Company LLC

Needham ratingCartesian TherapeuticsImmuneering
10/03 09:23 defenseworld.net

Immuneering (NASDAQ:IMRX) Receives Buy Rating from Needham & Company LLC

Needham ratingCartesian TherapeuticsImmuneering
Comments
Loading...
0